UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
July 19, 2023 5:30 P.M.
Form:
S-1
CIK:
0001737523
Company Name:
BioNexus Gene Lab Corp
File Number:
333-269753